Articles published in Cancer Science & Therapy have been cited by esteemed scholars and scientists all around the world.
Cancer Science & Therapy has got h-index 27, which means every article in Cancer Science & Therapy has got 27 average citations.
Following are the list of articles that have cited the articles published in Cancer Science & Therapy.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|---|
Total published articles |
57 | 46 | 70 | 59 | 42 | 78 | 71 |
Research, Review articles and Editorials |
3 | 4 | 18 | 22 | 27 | 26 | 69 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
41 | 45 | 52 | 37 | 15 | 52 | 2 |
Conference proceedings |
0 | 21 | 45 | 12 | 0 | 162 | 404 |
Citations received as per Google Scholar, other indexing platforms and portals |
4129 | 3358 | 294 | 348 | 345 | 373 | 344 |
Journal total citations count | 5332 |
Journal impact factor | 2.06 |
Journal 5 years impact factor | 2.85 |
Journal cite score | 6.17 |
Journal h-index | 27 |
Journal h-index since 2019 | 18 |
D Badave K, A Khan A, Y Rane S. Anticancer Vitamin K3 Analogs: A Review. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents). 2016 Aug 1;16(8):1017-30. |
|
Ivanova D, Zhelev Z, Lazarova D, Getsov P, Bakalova R, Aoki I. Vitamins C and K3: a powerful redox system for sensitizing leukemia lymphocytes to everolimus and barasertib. Anticancer research. 2018 Mar 1;38(3):1407-14. |
|
Gilloteaux J, Lau HL, Gourari I, Neal D, Jamison JM, Summers JL. Apatone® induces endometrioid ovarian carcinoma (MDAH 2774) cells to undergo karyolysis and cell death by autoschizis: A potent and safe anticancer treatment. Translational Research in Anatomy. 2015 Dec 1;1:25-39. |
|
Cano MI, Segatto M. Homeostasis of DNA Integrity. InTelomeres, Diet and Human Disease 2017 Aug 30 (pp. 1-24). CRC Press. |
|
Segatto M, Cano MI. Homeostasis of DNA Integrity. |
|
Wojdyla L, Frakes M, Harrington K, Stone A, Puri N. Telomerase-Related Proteins 42. Cancer Therapeutic Targets. 2017:467. |
|
Stuart MJ, Kelsey S, inventors; Geron Corp, assignee. Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms. United States patent US 9,375,485. 2016 Jun 28. |
|
Shirgahi Talari F, Bagherzadeh K, Golestanian S, Jarstfer M, Amanlou M. Potent human telomerase inhibitors: molecular dynamic simulations, multiple pharmacophore-based virtual screening, and biochemical assays. Journal of chemical information and modeling. 2015 Dec 2;55(12):2596-610. |
|
Man RJ, Chen LW, Zhu HL. Telomerase inhibitors: a patent review (2010–2015). Expert opinion on therapeutic patents. 2016 Jun 2;26(6):679-88. |
|
Sobinoff AP, Pickett HA. Alternative lengthening of telomeres: DNA repair pathways converge. Trends in Genetics. 2017 Sep 29. |
|
R Reddel R. Telomere maintenance mechanisms in cancer: clinical implications. Current pharmaceutical design. 2014 Dec 1;20(41):6361-74. |
|
Mannarreddy P, Denis M, Munireddy D, Pandurangan R, Thangavelu KP, Venkatesan K. Cytotoxic effect of Cyperus rotundus rhizome extract on human cancer cell lines. Biomedicine & Pharmacotherapy. 2017 Nov 1;95:1375-87. |
|
Ma CC, Li H, Wan RZ, Liu ZP. Developments of DNA-dependent protein kinase inhibitors as anticancer agents. Mini reviews in medicinal chemistry. 2014 Oct 1;14(11):884-95. |
|
å¢志红, 庞æ•Â红. 大肠癌组织ä¸Â多è¯è€Âè¯基因的表达åŠæ„Â义. æµ·å—医å¦院å¦报. 2015;21(11):1584-6. |
|
å«佳丽, é‚“è¿°æº. 姜黄素抗肿瘤机制的ç â€Ã§Â©Â¶Ã¨Â¿â€ºÃ¥Â±â€¢. æµ·å—医å¦. 2016;27(17):2828-31. |
|
刘其秀, 樊高飞, å´旸, æŽ继德, 范平çâ€Å¸. é¶动脉çŒ注维拉帕米和化疗è¯物治疗éžå°Â细胞肺癌的临床ç â€Ã§Â©Â¶. 肿瘤å¦æ‚志. 2016;22(11):957-61. |
|
谢婉莹, 欧阳鑫, 江冠民, 张秋桂. 姜黄素抗黑色素瘤分åÂÂ机制ç â€Ã§Â©Â¶Ã¨Â¿â€ºÃ¥Â±â€¢. 现代肿瘤医å¦. 2015;23(9):1319-21. |
|
å¶嘉诺, 郑åÂÅ¡, 朱莹æ°, 陶丽. ä¸Âè¯æÂÂå–物逆转结直肠癌多è¯è€Âè¯的ç â€Ã§Â©Â¶Ã¨Â¿â€ºÃ¥Â±â€¢. å‰林ä¸Â医è¯. 2017;37(4):429-32. |
|
Jiang K, Shen M, Xu W. Arginine, glycine, aspartic acid peptide-modified paclitaxel and curcumin co-loaded liposome for the treatment of lung cancer: in vitro/vivo evaluation. International journal of nanomedicine. 2018;13:2561. |
|
Bharate SB, Vishwakarmaa RA. Prashant Joshi, Samsher Singh, b, c Abubakar Wani, d Sadhana Sharma, b, d Shreyans K. Jain, b, e Baljinder Singh, b, e Bishan D. Gupta, e Naresh K. Satti, e Surrinder Koul, f Inshad A. Khan, b, c,* Ajay Kumar, d. development.;20:1. |
|
Cancer Science & Therapy received 5332 citations as per Google Scholar report